Pharmacoeconomics: Economic Evaluation of Pharmaceuticals

Kevin A. Schulman, Henry A. Glick, Daniel Polsky, Shelby D. Reed

Research output: Chapter in Book/Report/Conference proceedingChapter


Ongoing concerns about the costs of medical care have led both purchasers and producers of pharmaceuticals to realize that the cost of drugs is not limited to their purchase price. Accompanying costs of preparation, administration, monitoring for and treating side effects, and the economic consequences of successful treatment are all influenced by the clinical and pharmacologic properties of pharmaceutical products. Thus, in addition to differences in efficacy and safety, differences in efficiency (or the effectiveness of the therapy in clinical practice compared with its cost) distinguish drugs from one another. In this chapter, the authors discuss the importance of applying economic concepts to the study of pharmaceuticals, introduce clinical economics and the application of these concepts to pharmaceutical research, review methodologic issues addressed by investigators conducting pharmacoeconomic studies, and offer examples of pharmacoeconomic research.

Original languageEnglish (US)
Title of host publicationPharmacoepidemiology, Fifth Edition
Number of pages31
ISBN (Print)0470654759, 9780470654750
StatePublished - Jan 3 2012
Externally publishedYes


  • Clinical trial
  • Cost analysis
  • Cost-benefit analysis
  • Costs
  • Drug costs
  • Health resources
  • Health-care costs
  • Health-services research
  • Outcome and process assessment (health care)
  • Quality of life

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)


Dive into the research topics of 'Pharmacoeconomics: Economic Evaluation of Pharmaceuticals'. Together they form a unique fingerprint.

Cite this